Letter to share holdersHeres the bottom line InMed has never been in a better position scientifically, financially, and with our outstanding leadership team than we are today. I would like to take this opportunity to express my gratitude to our incredibly dedicated and diligent in-house team at InMed, as well as our industry partners, for exceptional work on multiple fronts. Without their skills and daily commitment to execution on InMeds programs, we would not be able to share these many achievements of 2018 with you here. I would also like to express my gratitude to you, our valued shareholder, for your continued support in achieving all that we did in 2018, and I look forward to sharing our next round of successes on the scientific and business goals we have set for 2019. We are delighted to have you as a partner as we continue to establish InMed as a global leader in cannabinoid-based therapeutics. On behalf of the entire InMed team, thank you for your continued support. Sincerely, Eric A. Adams President and Chief Executive Officer InMed Pharmaceuticals Inc.